Doximity Stock Surges Over 30% Following Strong Earnings and Upgraded Guidance

The telehealth platform exceeded Wall Street expectations with a 25% revenue growth and significant gains from AI-driven tools.

Doximity reported fiscal Q3 revenue of $168.6 million, a 25% year-over-year increase, surpassing analysts' expectations of $152.8 million.
Adjusted earnings per share reached $0.45, exceeding the predicted $0.34, with net income rising to $75.2 million from $48 million a year earlier.
The company raised its full-year revenue guidance to $564.6-$565.6 million, well above prior forecasts of $540 million.
AI-driven tools contributed significantly, with a 60% quarter-over-quarter growth, and over 610,000 unique providers engaged with Doximity's clinical workflow tools.
Analysts upgraded the stock's price target, citing strong margins, accelerating growth, and contributions from new products like the client portal.